Charles River has expertise in all aspects of drug discovery chemistry, including in silico, medicinal and synthetic, route development and optimization, purification and scale-up activities. Our scientists possess a wealth of experience from leading pharmaceutical and biotechnology companies and are well-equipped to address the challenges of drug discovery projects and deliver high-quality outcomes.

As your partner, we’re focused on ensuring that your strategic goals for clinical candidate delivery are met in a time- and cost-efficient manner, and it is every Charles River project team’s mission to deliver on this key objective. In the past 15 years, we have established the enviable record of delivering 63 preclinical candidates through our numerous integrated drug discovery collaborations, 27% of which have progressed to clinical proof-of-concept or beyond, compared to the industry standard of 12–24%.1

chart of drug candidates by TA

Reference
1Nature Drug Discovery, 2010, 9, 203; Drug Discovery Today, 2003, 8(23), 1067; Drug Discovery Today, 2013, 19(3), 341.